🕵️ Lifecore Biomedical, Inc. \DE\ ($LFCR)
SEC insider & ownership activity, last 12 months · CIK 1005286 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. 22NW Fund, LP trimmed 7.5% → 6.7%; 22NW, LP trimmed 7.5% → 6.7%. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Legion Partners Asset Management, LLC | 17.1% | 13D | Jun 30, 2026 | filing ↗ | |
| Raymond T. White | 17.1% | 13D | Jun 30, 2026 | filing ↗ | |
| Christopher S. Kiper | 17.1% | 13D | Jun 30, 2026 | filing ↗ | |
| Legion Partners Holdings, LLC | 17.1% | 13D | Jun 30, 2026 | filing ↗ | |
| Legion Partners, LLC | 16.9% | 13D | Jun 30, 2026 | filing ↗ | |
| Legion Partners, L.P. I | 15.6% | 13D | Jun 30, 2026 | filing ↗ | |
| 22NW Fund, LP | 11.1% | 13D | Dec 23, 2024 | filing ↗ | |
| 22NW, LP | 11.1% | 13D | Dec 23, 2024 | filing ↗ | |
| 22NW Fund GP, LLC | 11.1% | 13D | Dec 23, 2024 | filing ↗ | |
| 22NW GP, Inc. | 11.1% | 13D | Dec 23, 2024 | filing ↗ | |
| Aron R. English | 11.1% | 13D | Dec 23, 2024 | filing ↗ | |
| Greenhaven ROAD Investment Management, L.P. | 9.8% | 13G | Feb 14, 2025 | filing ↗ | |
| MVM Funds, LLC | 9.8% | 13G | Feb 14, 2025 | filing ↗ | |
| Scott Miller | 9.8% | 13G | Feb 14, 2025 | filing ↗ | |
| 22NW Fund, LP | 6.7% | 13D | Jun 30, 2026 | filing ↗ | |
| 22NW, LP | 6.7% | 13D | Jun 30, 2026 | filing ↗ | |
| 22NW Fund GP, LLC | 6.7% | 13D | Jun 30, 2026 | filing ↗ | |
| 22NW GP, Inc. | 6.7% | 13D | Jun 30, 2026 | filing ↗ | |
| Aron R. English | 6.7% | 13D | Jun 30, 2026 | filing ↗ | |
| Blackrock, Inc. | 5.4% | 13G | Jul 29, 2026 | filing ↗ | |
| Greenhaven ROAD Capital Fund 2, L.P. | 5.4% | 13G | Feb 14, 2025 | filing ↗ | |
| Legion Partners, L.P. II | exited | 13D | Jun 30, 2026 | filing ↗ | |
| Bryson O. Hirai-Hadley | exited | 13D | Jun 30, 2026 | filing ↗ | |
| Nathaniel Calloway | exited | 13D | Jun 30, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jun 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 4, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 4, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Earnings (2.02) | Mar 16, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 16, 2026 | filing ↗ |
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 (5.08) | Mar 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 17, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Shareholder vote (5.07) | Oct 29, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 22, 2025 | filing ↗ |
| Auditor change (4.01) | Aug 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |